Daxor Total Liabilities 2010-2011 | DXR

Daxor total liabilities from 2010 to 2011. Total liabilities can be defined as the total value of all possible claims against the corporation.
Daxor Annual Total Liabilities
(Millions of US $)
2011 $50
2010 $44
2009 $28
Daxor Quarterly Total Liabilities
(Millions of US $)
2011-12-31 $50
2011-09-30 $51
2011-06-30 $51
2011-03-31 $47
2010-12-31 $44
2010-09-30 $38
2010-06-30 $37
2010-03-31 $40
2009-12-31 $28
2009-09-30 $29
2009-06-30 $30
2009-03-31 $30
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.040B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.128B 0.00
Quest Diagnostics (DGX) United States $16.942B 17.17
DaVita (DVA) United States $12.579B 16.27
Encompass Health (EHC) United States $9.173B 21.63
Chemed (CHE) United States $7.854B 24.14
Elanco Animal Health (ELAN) United States $5.650B 13.45
RadNet (RDNT) United States $5.092B 112.75
Option Care Health (OPCH) United States $4.083B 19.35
Amedisys (AMED) United States $3.010B 21.42
LifeStance Health (LFST) United States $2.958B 0.00
Addus HomeCare (ADUS) United States $2.273B 26.67
Astrana Health (ASTH) United States $1.658B 22.68
U.S Physical Therapy (USPH) United States $1.313B 34.52
Pennant (PNTG) United States $0.887B 35.86
Aveanna Healthcare Holdings (AVAH) United States $0.871B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00